Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.

Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.

OBJECTIVE: To determine whether elevated levels of the angiogenic cytokine vascular endothelial growth factor (VEGF), detected on presentation to an early arthritis clinic, are associated with the development of chronic and erosive arthritis. METHODS: Concentrations of VEGF and its soluble receptor,...

Bibliografiset tiedot
Päätekijät:	Ballara, S, Taylor, P, Reusch, P, Marmé, D, Feldmann, M, Maini, R, Paleolog, E
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2001

Samankaltaisia teoksia

Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
Tekijä: Maini, R, et al.
Julkaistu: (2000)

Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.
Tekijä: Maini, R, et al.
Julkaistu: (1999)

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis.
Tekijä: Paleolog, E, et al.
Julkaistu: (1998)

Vascular endothelial growth factor signalling in endothelial cell survival: a role for NFkappaB.
Tekijä: Grosjean, J, et al.
Julkaistu: (2006)

VEGF release is associated with hypoxia in inflammatory arthritis
Tekijä: Taylor, P, et al.
Julkaistu: (2001)

VEGF release is associated with hypoxia in inflammatory arthritis(.)
Tekijä: Taylor, P, et al.
Julkaistu: (2000)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
Tekijä: Feldmann, M, et al.
Julkaistu: (1997)

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.
Tekijä: Paleolog, E, et al.
Julkaistu: (1996)

Advanced glycation end products (AGE) enhance vascular endothelial growth factor (VEGF) production in promonocytic leukaemia THP-1 cells
Tekijä: Pertńaska-Marczewska, M, et al.
Julkaistu: (2003)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
Tekijä: Williams, R, et al.
Julkaistu: (2000)

Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells.
Tekijä: Paleolog, E, et al.
Julkaistu: (1994)

Contrasting effects of interferon gamma and interleukin 4 on responses of human vascular endothelial cells to tumour necrosis factor alpha.
Tekijä: Paleolog, E, et al.
Julkaistu: (1992)

Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply
Tekijä: Taylor, P, et al.
Julkaistu: (2001)

Role of pro-inflammatory cytokines in rheumatoid arthritis.
Tekijä: Brennan, F, et al.
Julkaistu: (1998)

Rapidly Destructive Inflammatory Arthritis of the Hip
Tekijä: Jenny Shu, et al.
Julkaistu: (2014-01-01)

VEGF release is associated with reduced oxygen tensions in experimental inflammatory arthritis.
Tekijä: Etherington, P, et al.
Julkaistu: (2002)

Role of vascular endothelial growth factor in pathogenesis of rheumatoid arthritis
Tekijä: Z S Marchenko, et al.
Julkaistu: (2005-02-01)

Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis.
Tekijä: Jain, A, et al.
Julkaistu: (2001)

Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy.
Tekijä: Taylor, P
Julkaistu: (2005)

Advanced glycation end products (AGEs) augment production of vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF alpha) in human monocyte-derived macrophages.
Tekijä: Pertynska-Marczewska, M, et al.
Julkaistu: (2003)

Serum Vascular Endothelial Growth Factor Levels and Uterine Fibroid Volume
Tekijä: Rajuddin Rajuddin, et al.
Julkaistu: (2020-04-01)

Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?
Tekijä: Feldmann, M, et al.
Julkaistu: (2004)

Vascular endothelium--role in chronic inflammatory disease.
Tekijä: Kiriakidis, S, et al.
Julkaistu: (2013)

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
Tekijä: Taylor, P, et al.
Julkaistu: (2000)

Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair.
Tekijä: Chu, C, et al.
Julkaistu: (1992)

Raised circulating tenascin-C in rheumatoid arthritis.
Tekijä: Page, T, et al.
Julkaistu: (2012)

Is the vasculature a potential therapeutic target in arthritis?
Tekijä: Taylor, P, et al.
Julkaistu: (2006)

Dysregulated Sulfide Metabolism in Multiple Sclerosis: Serum and Vascular Endothelial Inflammatory Responses
Tekijä: Pooja Veerareddy, et al.
Julkaistu: (2022-09-01)

Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
Tekijä: Williams, R, et al.
Julkaistu: (2007)

Destruction of vascular endothelial glycocalyx during formation of pre-metastatic niches
Tekijä: Rui Qu, et al.
Julkaistu: (2024-04-01)

Content of vascular endothelial growth factor in blood serum and gastric juice in children with chronic inflammatory diseases of stomach and duodenum
Tekijä: Zavyalova O.V., et al.
Julkaistu: (2014-03-01)

Analysis of cytokine expression in rheumatoid synovium has provided new insights into the pathogenesis of rheumatoid arthritis and new therapeutic opportunities.
Tekijä: Feldmann, M, et al.
Julkaistu: (2001)

Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.
Tekijä: Feldman, M, et al.
Julkaistu: (1998)

Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis.
Tekijä: Hermann, J, et al.
Julkaistu: (1998)

Fc Gamma Receptors as Regulators of Bone Destruction in Inflammatory Arthritis
Tekijä: Yuyue Zuo, et al.
Julkaistu: (2021-06-01)

Antilipid A monoclonal antibody HA-1A decreases the capacity of bacterial lipopolysaccharide to activate human vascular endothelial cells by an immune adherence mechanism.
Tekijä: Paleolog, E, et al.
Julkaistu: (1993)

Rheumatoid arthritis: introduction.
Tekijä: Feldmann, M, et al.
Julkaistu: (1998)

Serum Levels of Asymmetric Dimethylarginine and Apelin as Potential Markers of Vascular Endothelial Dysfunction in Early Rheumatoid Arthritis
Tekijä: Manuela Di Franco, et al.
Julkaistu: (2012-01-01)

Vascular Inflammatory Diseases and Endothelial Phenotypes
Tekijä: Jenita Immanuel, et al.
Julkaistu: (2023-06-01)

Angiopoietin-2, vascular endothelial growth factor family, and heparin binding endothelial growth factor are associated with subclinical atherosclerosis in rheumatoid arthritis
Tekijä: Anna Pàmies, et al.
Julkaistu: (2024-12-01)